We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+27.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
-$76M
Cap. Flow
-$97.6M
Cap. Flow %
-49.58%
Top 10 Hldgs %
44.5%
Holding
160
New
26
Increased
14
Reduced
15
Closed
66

Top Buys

Rank Stock Value
1
ATXS
Astria Therapeutics
ATXS
+$9.39M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$4.07M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.73M
4
OTLK icon
Outlook Therapeutics
OTLK
+$3.62M
5
REPL icon
Replimune Group
REPL
+$3.32M

Top Sells

Rank Stock Value
1
CCXI
ChemoCentryx, Inc.
CCXI
+$8.27M
2
INSM icon
Insmed
INSM
+$5.77M
3
MBTC
Nocturne Acquisition Corporation Ordinary Shares
MBTC
+$5.17M
4
BCAB icon
BioAtla
BCAB
+$4.26M
5
ILMN icon
Illumina
ILMN
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 88.67%
2 Financials 5.8%
3 Communication Services 0.42%
4 Industrials 0.36%
5 Materials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXH
151
DELISTED
Industrial Human Capital, Inc.
AXH
– –
-100,000
Closed -$1.01M
AXH.WS
152
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
– –
-100,000
Closed -$2K
SRSAW
153
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
– –
-75,000
Closed -$2K
SRSA
154
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
– –
-225,000
Closed -$2.25M
BLSA
155
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
– –
-100,000
Closed -$1M
ADRT.WS
156
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
– –
-112,500
Closed -$5K
CCXI
157
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-160,000
Closed -$8.27M
TMPMW
158
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
– –
-84,666
Closed -$2K
TMPM
159
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
– –
-254,000
Closed -$2.54M
RACYU
160
DELISTED
Relativity Acquisition Corp. Unit
RACYU
– –
-100,000
Closed -$1.01M
3 4 5 6
7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Altium Capital Management held 160 positions worth $197M, down 28% from $273M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Altium Capital Management withdrew a net $97.6M in Q4 2022, closing 66 positions and reducing 15 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $8.27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 79% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Altium Capital Management opened a new position in Tandem Diabetes Care worth $4.05M.

  • Altium Capital Management's largest Q4 2022 buy was Tandem Diabetes Care: 90,000 shares worth $4.05M.
  • Altium Capital Management added most to Astria Therapeutics in Q4 2022, an estimated $9.39M increase.
  • Altium Capital Management's biggest Q4 2022 reduction was Chinook Therapeutics, Inc. Common Stock, cutting an estimated $3.1M.
  • Altium Capital Management fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $8.27M.
  • Altium Capital Management's ten largest holdings make up 45% of its $197M portfolio in Q4 2022.
  • Altium Capital Management opened 26 new positions and closed 66 in Q4 2022.
  • Altium Capital Management's portfolio value fell 28% quarter-over-quarter to $197M.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.